Novasep invest €30m in ‘world’s largest chromatography plant’
October 11, 2012Manufacturing and Production API, Novasep
French purification specialist Novasep has said it plans to invest €30 million in a new plant at its site in …
GSK signs TB vaccine agreement
October 11, 2012Research and Development, Sales and Marketing Aeras, GSK, TB
GlaxoSmithKline Vaccines has signed a deal with US not-for-profit biotech Aeras to develop a new vaccine which will treat tuberculosis …
RSA announces three appointments to its global team
October 11, 2012François Martin, Jana Kurtova, Naja Kjeldsen, rsa
Life sciences executive search and interim management specialists RSA has announced three new appointments. Dr François Martin (pictured) has been …
Government showcases dementia research
October 11, 2012Sales and Marketing Cameron, DH, UK, dementia
The government is attempting to encourage international organisations to help the UK’s efforts to find better treatments for dementia. An …
Targacept cuts over a third of its staff
October 10, 2012Research and Development
Targacept is to make 38% of its staff redundant and cease laboratory operations by the end of the year as …
Hunt prioritises elderly and cancer
October 10, 2012Sales and Marketing
Health secretary Jeremy Hunt yesterday put the care of the elderly at the centre of his vision for public health …
AZ licences renal disease compound
October 9, 2012Research and Development, Sales and Marketing Ardelyx, AstraZeneca, NHE3
AstraZeneca has signed an agreement giving it worldwide exclusive rights to California-based Ardelyx’s NHE3 inhibitor programme targeting liver and kidney …
Catalent and Parexel forge partnership
October 9, 2012Manufacturing and Production Catalent, Parexel
Catalent Pharma Solutions has formed an alliance with Parexel in a further boost to its aspirations in clinical trial material …
Novasep announces changes at the top
October 9, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development Novasep, Patrick Glaser, Roger-Marc Nicoud, manufacturing
Novasep has announced the appointment of Roger-Marc Nicoud, founder and chief executive, as non-executive chairman of the Board. The manufacturing …
DSM joins forces with Almac for biocatalysis
October 9, 2012Manufacturing and Production Almac, DSM
DSM Pharmaceutical Products has teamed up with Almac to offer biocatalysis services to customers in the drug industry. By working …
Olympus Biotech launches CMO services
October 9, 2012Manufacturing and Production CMO, Japan, Olympus
US-based Olympus Biotech has launched a contract manufacturing organisation (CMO) operation to complement its current focus on regenerative medicines. The …
Dr Reddy’s grows UK manufacturing base
October 9, 2012Manufacturing and Production CPS, Dow Pharma, Dr Reddy's, Mirfield
India’s Dr Reddy’s Laboratories has said it plans to increase its manufacturing operations in the UK with a round of …
Scotland ‘no’ to Avastin
October 9, 2012Sales and Marketing NICE, Roche, Scotland, avastin
Roche has slammed the Scottish Medicines Consortium (SMC)’s decision not to recommend Avastin for women with advanced ovarian cancer in …
Digital Pharma: what should we talk about?
October 8, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Facebook, Pfizer, digital pharma, social media, twiiter
The received wisdom today among the ‘digirati’ is that the pharmaceutical industry must join in the online conversation, and to …
Takeda to buy LigoCyte for $60 million
October 8, 2012Sales and Marketing LigoCyte, Takeda, norovirus
Takeda Pharmaceutical Company is to pay $60 million upfront to buy private US biopharma firm LigoCyte Pharmaceuticals in the next …
Sanofi’s Zaltrap data published
October 8, 2012Research and Development, Sales and Marketing Erbitux, Sanofi, Stivarga, Zaltrap, avastin
Detailed data from the Phase III trial of Sanofi’s newly-licenced anti-VEGF cancer drug Zaltrap, co-marketed with Regeneron, has been published. …
Chiltern announces new chief executive
October 8, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Jim Esinhart, chiltern
Contract research organisation Chiltern International has announced a successor to chief executive Glenn Kerkhof, who is stepping down to be …
NICE does Lucentis U-turn
October 5, 2012Sales and Marketing Lucentis, NICE, Novartis, Roche, avastin
NICE has done a U-turn over its previous verdict on Novartis’ Lucentis, now recommending the drug in draft guidance to …
Vernon named Digital Pioneer at PM Society awards
October 5, 2012Medical Communications Creative Lynx, GSK, PM Society Digital Awards, digital
A range of innovative digital programmes created by UK pharma companies and agencies were recognised at last night’s PM Society …
NHS under fire for ‘misdiagnosis’
October 5, 2012Sales and Marketing BHIVA, HIV, NHS
Patients with HIV infections are going unnoticed by the NHS while those with rare diseases are often being misdiagnosed. These …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
